| Product Code: ETC7659009 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Pharmacogenetic Testing Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Israel Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Israel Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Israel Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Israel Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Israel Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Israel Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Israel Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and adoption of personalized medicine in Israel |
4.2.2 Growing demand for precision medicine to optimize treatment outcomes |
4.2.3 Favorable government initiatives promoting pharmacogenetic testing |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for pharmacogenetic testing |
4.3.2 High costs associated with genetic testing procedures |
4.3.3 Lack of standardized guidelines for implementing pharmacogenetic testing |
5 Israel Pharmacogenetic Testing Market Trends |
6 Israel Pharmacogenetic Testing Market, By Types |
6.1 Israel Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Israel Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Israel Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Israel Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Israel Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Israel Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Israel Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Israel Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Israel Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Israel Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Israel Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Israel Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Israel Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Israel Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Israel Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Israel Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Israel Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Israel Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Israel Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Israel Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Israel Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Israel Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Israel Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Israel Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Israel Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Israel Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Israel Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Israel Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Israel Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Israel Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Israel Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Israel Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Israel Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Israel Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Israel Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Israel Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Israel Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Israel Pharmacogenetic Testing Market Export to Major Countries |
7.2 Israel Pharmacogenetic Testing Market Imports from Major Countries |
8 Israel Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare providers offering pharmacogenetic testing services |
8.2 Rate of adoption of pharmacogenetic testing by healthcare institutions |
8.3 Investment in research and development of new pharmacogenetic testing technologies |
9 Israel Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Israel Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Israel Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Israel Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Israel Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Israel Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Israel Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Israel Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Israel Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here